A research team led by Professor Stephen Hart (UCL Great Ormond Street Institute of Child Health) have developed a new way to deliver drugs that can shut down cancer mutations in neuroblastoma using tiny bubbles to deliver therapies directly to tumour cells.
Read: i News, More: UCL News